Literature DB >> 17768650

Long-term results of the Fontan operation.

D J Driscoll1.   

Abstract

Modifications of the Fontan operation can afford excellent palliation for many patients with a variety of forms of single ventricle. In properly selected patients who are good candidates, early and late survival can be as high as 95-97%. However, mortality is considerably higher for patients with risk factors for poor outcome. For high-risk patients, inclusion of a fenestration may reduce morbidity and mortality. Important long-term undesirable events include the ongoing risk of death, arrhythmias, protein-losing enteropathy, and cardiac failure. The key to excellent long-term outcome is proper selection of patients for the operation.

Entities:  

Mesh:

Year:  2007        PMID: 17768650     DOI: 10.1007/s00246-007-9003-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Long-term results of the Fontan operation for double-inlet left ventricle.

Authors:  Michael G Earing; Frank Cetta; David J Driscoll; Douglas D Mair; David O Hodge; Joseph A Dearani; Francisco J Puga; Gordon K Danielson; Patrick W O'Leary
Journal:  Am J Cardiol       Date:  2005-07-15       Impact factor: 2.778

2.  Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation.

Authors:  P Monagle; A Cochrane; B McCrindle; L Benson; W Williams; M Andrew
Journal:  J Thorac Cardiovasc Surg       Date:  1998-03       Impact factor: 5.209

3.  Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor?

Authors:  J William Gaynor; Nancy D Bridges; Mitchell I Cohen; William T Mahle; William M Decampli; James M Steven; Susan C Nicolson; Thomas L Spray
Journal:  J Thorac Cardiovasc Surg       Date:  2002-02       Impact factor: 5.209

4.  Surgical repair of tricuspid atresia.

Authors:  F Fontan; E Baudet
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

5.  Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk.

Authors:  N D Bridges; J E Lock; A R Castaneda
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

6.  Cardiopulmonary function in adult patients late after Fontan repair.

Authors:  D A Harrison; P Liu; J E Walters; J M Goodman; S C Siu; G D Webb; W G Williams; P R McLaughlin
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

7.  Long-term results of the lateral tunnel Fontan operation.

Authors:  C Stamm; I Friehs; J E Mayer; D Zurakowski; J K Triedman; A M Moran; E P Walsh; J E Lock; R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2001-01       Impact factor: 5.209

8.  Outcome after the single-stage, nonfenestrated Fontan procedure.

Authors:  D T Hsu; J M Quaegebeur; F F Ing; E J Selber; J M Lamour; W M Gersony
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

9.  Risk factors for atrial tachyarrhythmias after the Fontan operation.

Authors:  M Gelatt; R M Hamilton; B W McCrindle; R M Gow; W G Williams; G A Trusler; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1994-12       Impact factor: 24.094

10.  Effect of right ventricular anatomy on the cardiopulmonary response to exercise. Implications for the Fontan procedure.

Authors:  J Rhodes; R P Garofano; F O Bowman; G P Grant; F Z Bierman; W M Gersony
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

View more
  16 in total

1.  Fontan "Ten Commandments" revisited and revised.

Authors:  Herbert J Stern
Journal:  Pediatr Cardiol       Date:  2010-10-20       Impact factor: 1.655

2.  Anaesthetic management of a patient with Fontan physiology for electrophysiology study and catheter ablation.

Authors:  Denise Yan Yin Lim; Thangavelautham Suhitharan; Harikrishnan Kothandan
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 3.  Long term negative pressure ventilation: Rescue for the failing fontan?

Authors:  Shriprasad R Deshpande; Kevin O Maher
Journal:  World J Cardiol       Date:  2014-08-26

4.  Longitudinal study of anthropometry in Fontan survivors: Pediatric Heart Network Fontan study.

Authors:  Linda M Lambert; Brian W McCrindle; Victoria L Pemberton; Danielle Hollenbeck-Pringle; Andrew M Atz; Chitra Ravishankar; M Jay Campbell; Carolyn Dunbar-Masterson; Karen Uzark; Martha Rolland; Felicia L Trachtenberg; Shaji C Menon
Journal:  Am Heart J       Date:  2020-04-04       Impact factor: 4.749

Review 5.  Congenital Heart Disease and the Liver.

Authors:  Moira B Hilscher; Patrick S Kamath
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-11-06

6.  Quality of life, health status, and depression: comparison between adolescents and adults after the Fontan procedure with healthy counterparts.

Authors:  Nancy A Pike; Lorraine S Evangelista; Lynn V Doering; Jo-Ann Eastwood; Alan B Lewis; John S Child
Journal:  J Cardiovasc Nurs       Date:  2012 Nov-Dec       Impact factor: 2.083

7.  A practical and less invasive total cavopulmonary connection sheep model.

Authors:  Dongfang Wang; Mark Plunkett; Guodong Gao; Xiaoqin Zhou; Cherry Ballard-Croft; Hassan Reda; Joseph B Zwischenberger
Journal:  ASAIO J       Date:  2014 Mar-Apr       Impact factor: 2.872

8.  Prevalence of Sleep-Disordered Breathing in a Cohort of Adult Fontan Patients.

Authors:  Stevens Cg; Jacobsen Rm; Khanna Ad; Yeung E; Kollengode M; Morgan G; Kay J
Journal:  Pediatr Cardiol       Date:  2020-06-23       Impact factor: 1.655

9.  Transesophageal echocardiography of intracardiac thrombus in congenital heart disease and atrial flutter: the importance of thorough examination of the Fontan.

Authors:  Nida Yousef; Molly Philips; Ira Shetty; Vivian Wei Cui; Frank Zimmerman; David A Roberson
Journal:  Pediatr Cardiol       Date:  2014-04-20       Impact factor: 1.655

Review 10.  Immunoglobulin replacement therapy in children.

Authors:  Maria Garcia-Lloret; Sean McGhee; Talal A Chatila
Journal:  Immunol Allergy Clin North Am       Date:  2008-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.